Full text is available at the source.
Abstract
Alterations in gut microbial composition and metabolites may influence Parkinson's disease (PD).
- Dysbiosis in gut microbiota can impact both the enteric and central nervous systems.
- The microbiota-gut-brain axis may play a role in the development of CNS diseases.
- Specific microbial products are associated with gut inflammation and neuroinflammation.
- Future research should investigate particular gut microbes or metabolites linked to PD.
- Microbiota-targeted interventions, including antibiotics and probiotics, may improve host health.
Simplified